Skip to content
drillr.ai
Sign up

GLSI

Greenwich LifeSciences, Inc.

NASDAQ · Healthcare · Biotechnology · US

$15.95
+2.05%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue—1.8K3.6K3.6K3.6K
Gross Profit—(1.8K)(3.6K)(3.6K)(3.6K)
Operating Expenses
R&D Expense15.8M17.2M15.5M7.7M6.5M
SG&A Expense2.3M2.2M2.2M1.6M1.6M
General & Admin Expense2.3M——1.6M1.6M
Selling & Marketing Expense—————
Other Expenses3.8M————
Total Operating Expenses21.9M19.4M17.6M9.3M8.0M
Cost and Expenses21.9M19.4M17.6M9.3M8.0M
Operating Income (EBIT)(21.9M)(19.4M)(17.6M)(9.3M)(8.0M)
Non-Operating
Interest Income186.6K89.7K223.0K436.1K215.0K
Interest Expense—————
Net Interest Income186.6K89.7K223.0K436.1K215.0K
Other Non-Op Income/Expense186.6K89.7K223.0K436.1K215.0K
Non-Operating Income (excl Interest)(186.6K)(89.7K)(223.0K)(436.1K)(215.0K)
EBT (Pre-Tax Income)(21.7M)(19.4M)(17.4M)(8.9M)(7.8M)
Income Tax Expense—————
Bottom Line
Net Income(21.7M)(19.4M)(17.4M)(8.9M)(7.8M)
Earnings from Cont. Ops(21.7M)(19.4M)(17.4M)(8.9M)(7.8M)
Earnings from Discont. Ops—————
Bottom Line Net Income(21.7M)(19.4M)(17.4M)(8.9M)(7.8M)
Per Share
Basic EPS($1.54)($1.43)($1.21)($0.69)($0.61)
Diluted EPS($1.54)($1.43)($1.21)($0.69)($0.61)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding14.6M13.5M13.0M12.8M12.9M
Diluted Shares Outstanding14.6M13.5M13.0M12.8M12.9M
Profitability Metrics
EBITDA(21.7M)(19.4M)(17.4M)(8.9M)(7.8M)
D&A1.8K1.8K3.6K3.6K3.6K
EBIT(21.7M)(19.4M)(17.4M)(8.9M)(7.8M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026